Session Information
2007 BIO International Convention
Click here to go to the previous page
Winning Without an IPO: Creative Strategies for Bypassing the Public Offering
Track : Emerging Company Issues
Program Code: ECI040
Date: Monday, May 7, 2007
Time: 11:00 AM to 12:30 PM  
Location: 210 A
CHAIR :
Steve Davis, Shareholder, Heller Ehrman LLP
SPEAKER (S):
Jason Bernhard, Global Co-Chair, Life Sciences Group, Lazard
Jeff Rona, Chief Business Officer, GlobeImmune Inc.
Timothy Keating, President, Keating Investments
Chris Ehrlich, , Venture Member, InterWest Partners
Description
As your company races to the finish line, be aware that the winner's circle may no longer hold an IPO. Join us for a review of financing vehicles available to mezzanine-stage private companies, the pros and cons of each and a discussion of The Street's perception of alternative strategies for achieving liquidity.



Objectives:
  • Help CEOs and CFOs examine the pros and cons of various alternative financing vehicles and exit strategies in a slow IPO market.

  • Provide insights into some of the lesser known financing vehicles such as SPACs, shells and reverse mergers along with the advantages and disadvantages of each.

  • Help CEOs and CFOs identify who their most interested and likely purchasers could be when an acquisition is a likely scenario.


  • Streaming Audio with
    PowerPoint Slides
    (Code: ECI040)
      
    This session is a part of: